SBLOF Revenue

In the fiscal year ending March 31, 2025, Shin Nippon Biomedical Laboratories had annual revenue of 32.41B JPY with 22.55% growth. Shin Nippon Biomedical Laboratories had revenue of 10.18B in the quarter ending March 31, 2025, with 20.23% growth.

Revenue

32.41B JPY

Revenue Growth

+22.55%

P/S Ratio

1.80

Revenue / Employee

22.57M JPY

Employees

1,436

Market Cap

390.17M USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	32.41B	5.96B	22.55%
Mar 31, 2024	26.45B	1.36B	5.42%
Mar 31, 2023	25.09B	7.34B	41.37%
Mar 31, 2022	17.75B	2.64B	17.46%
Mar 31, 2021	15.11B	549.00M	3.77%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo Inc.	1.73B
Veradigm	588.02M
Elite Pharmaceuticals	70.00M
Tian'an Technology Group	1.78M
Glass House Brands	215.62M
Northwest Biotherapeutics	1.47M
American Oncology Network	1.76B
Silence Therapeutics	27.70M

Revenue Rankings